On February 28, 2024, the workers of Gansu Fuzheng Pharmaceutical Technology Co., Ltd. were busy packing boxes.
Gansu Jinling Group Pharmaceutical Co., Ltd. produces Guiqi Panax notoginseng oral liquid.
People are diligent and compete for the day and night early, and the state is "full" and busy. The strong smell of the New Year has not completely dissipated, and the various pharmaceutical companies in our city have been in full swing and sprinting to a "good start".
On February 28, the reporter saw in the production workshop of Fuzheng Pharmaceutical Co., Ltd., Minkou Town, Anding District, that the production lines were running at full capacity, and the technicians were skillfully operating the machines.
On February 28, 2024, in the inspection room of Fuzheng Pharmaceutical, workers were busy inspecting.
We resumed work on February 14, and all staff arrived at work on the 15th, resuming work and production in a safe and orderly manner. Zhang Ruiju, the person in charge of the quality of Gansu Fuzheng Pharmaceutical Science and Technology Co., Ltd., said that the company's main Zhenqi Fuzheng series products are based on the city's authentic medicinal material Astragalus membranaceus, with an annual consumption of more than 2,000 tons. Judging from the current customer demand and the feedback of the best businessmen, it is expected that this year's order volume will increase significantly compared with last year.
On February 28, 2024, the workshop of Fuzheng Pharmaceutical was in full swing.
Gansu Jinling Group Pharmaceutical Co., Ltd. has formed an industrial development pattern focusing on Chinese patent medicine preparations, focusing on the planting, research and development, processing and circulation of medicinal materials, and is a comprehensive enterprise integrating import and export business, R&D, production and deep processing of Chinese herbal medicines.
On February 28, 2024, workers of Jinling Group packed Guiqi Panax notoginseng oral liquid.
The reporter learned that in order to ensure that the annual plan formulated at the beginning of 2024 is completed on schedule, the company has put forward clear requirements for the resumption of work and production after the holiday.
According to statistics, there are 102 key processing enterprises of various types of traditional Chinese medicine in the city, and the production products include 7 categories of traditional Chinese medicine refined decoction pieces, formula granules, traditional Chinese medicine extracts, Chinese patent medicines, traditional Chinese medicine veterinary drugs, health care products and cosmetics, showing a diversified, serialized and high-value development trend.
In the spring, Dingxi City is making every effort to implement various measures to stabilize growth, continue to strengthen the guidance of operation scheduling, promote the construction of projects, dig deep into the potential of enterprises in the regulations, and promote the stable production and increase of existing enterprises, the production of new projects and the production of enterprises, and strive to increase the industrial added value above the scale by 7 from January to FebruaryMore than 5%, with the good growth in January and February, the industrial economy in the first quarter to achieve a "good start".
Reporter Zhang Lifang of Dingxi Rong ** Center.